News

GPs 'are not gaming QOF'

25-Jul-08

GPs in England exception report only 5 per cent of their patients and there is little evidence that widespread gaming of the quality framework occurs, UK research suggests.

Concerns had been raised that some GPs would exclude large numbers of patients to make more money.

But this latest study, which analysed clinical data from 96 per cent of practices in England, found that from April 2005 to March 2006, the average GP exception reported just 5.3 per cent of patients.

This is lower than the rate seen in the first year of the contract.

Lead researcher Professor Martin Roland, director of the National Primary Care Research and Development Centre, said: 'Exception reporting is an important part of the quality framework because it avoids perverse incentives for GPs to give their patients inappropriate treatment.

'Our results suggest that most GPs have been responsible in their use of exception reporting, though a small number need their behaviour monitored by PCTs.'

sanjay.tanday@haymarket.com

NEJM 2008; 359: 274-84.

Comment below and tell us what you think

Comments

Only registered users may comment. Log in now or register for a free account.

Login to comment


forgotten your password?

Healthcare Republic Forums

 

Registrar

nMRCGP exam update - Evidence for aspirin use

Current situation. Read more

RCGP curriculum - Introducing the GP curriculum

Dr Ben Riley and Dr Jayne Haynes explain what the curriculum is and why it is necessary. Read more

Alcohol problems in young people

Greater awareness of drinking problems is needed, say Professor Eileen Kaner and Ruth McGovern. Read more

Show all articles

 

Latest Clinical Articles

Altitude-related illness

Contributed by Dr Matthew Litchfield, GP, Nottingham and Dr James Milledge, retired consultant respi... Read more

Clinical Review - Subfertility in women

Contributed by Mr David Walker, consultant obstetrician and gynaecologist at the Royal United Hospit... Read more

Stable angina pectoris

Contributed by Dr Unni Krishnan, clinical research fellow in cardiology at the Glenfield Hospital, L... Read more

Show all clinical articles

MIMS Product News

New drug - Volibris

GSK has launched Volibris (ambrisentan) for the treatment of pulmonary arterial hypertension (WHO Cl... Read more

New drug - Thymoglobuline

Thymoglobuline is an immunosuppressant for the prophylaxis of graft rejection in renal or heart tra... Read more

New drug - Tyverb

Tyverb (lapatinib) is an oral antineoplastic agent that may provide women with an alternative option... Read more

Jobs

 

Job of the Week